3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
40
Triple Negative Breast Neoplasms
16
Carcinoma, Transitional Cell
14
Breast Neoplasms
14
Small Cell Lung Carcinoma
12
Urinary Bladder Neoplasms
11
Melanoma
10
Carcinoma, Hepatocellular
9
Neoplasms
8
Carcinoma, Renal Cell
8
Uterine Cervical Neoplasms
6
Neoplasm Metastasis
6
Lung Neoplasms
6
Colorectal Neoplasms
5
Ovarian Neoplasms
4
Lymphoma, Follicular
4
Lymphoma
4
Squamous Cell Carcinoma of Head and Neck
3
Recurrence
3
Prostatic Neoplasms
3
Leukemia, Myeloid, Acute
3
Cholangiocarcinoma
3
Brain Neoplasms
3
Stomach Neoplasms
2
Solid Tumors
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Kidney Neoplasms
2
Gallbladder Neoplasms
2
Fallopian Tube Neoplasms
2
Interventions
Lenalidomide
8
Dexamethasone
6
Calcium Dobesilate
6
Melphalan
3
elotuzumab
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
daratumumab
2
auricularum
2
Peripheral Blood Stem Cell Transplantation
2
Bortezomib
2
pomalidomide
1
piperine
1
pembrolizumab
1
ixazomib
1
ibrutinib
1
Watchful Waiting
1
Urination
1
Transplantation, Autologous
1
Stem Cell Transplantation
1
Receptors, Interleukin-6
1
Observation
1
Nivolumab
1
Metformin
1
Interleukin 1 Receptor Antagonist Protein
1
In Situ Hybridization, Fluorescence
1
IPH-2101
1
Granulocyte Colony-Stimulating Factor
1
Gene Expression Profiling
1
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Smoldering Multiple Myeloma
×
atezolizumab
×
Clear all
No trials found.